ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1343

Satisfaction with Rheumatoid Arthritis Care Is Related to Discordance with Providers’ Treatment Goals and Patients’ Reasons for Disagreement

Kelly O'Neill1, Pamela Sinicrope2, Cynthia Crowson3, Kathryne Marks4, Rachel Giblon5, Elena Myasoedova2 and John Davis2, 1Rheumatoid Patient Foundation, Winter Springs, FL, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic, Eyota, MN, 4Brigham and Women's Hospital, Boston, MA, 5Mayo Clinic, Rochester, MN, Rochester, MN

Meeting: ACR Convergence 2022

Keywords: Outcome measures, Patient reported outcomes, Qualitative Research, rheumatoid arthritis, Surveys

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: We previously reported on the incidence of shared treatment goal discussions which are associated with disease activity (DA) improvement and satisfaction within rheumatology care. Building on our previous reports, we aimed to gain insight into the nature of discordance in rheumatoid arthritis (RA) treatment goals and explore its relationship to patient satisfaction with care.

Methods: An anonymous online questionnaire was presented in 2019 on a secure survey system. U.S. residents ≥18 years of age with a self-reported RA diagnosis by a medical professional responded to questions on demographics, DA, diagnosis and DMARD history, and RA treatment goals. Participants were asked how their providers’ RA treatment goals differed from their own. Responses were assessed and coded thematically using qualitative content analysis to identify reasons their goals differed from their providers’. Responses were also coded for strong emotion, poor communication, and difference in outcome expectation (high or low). Relationships between patient demographics and discordance in treatment goals and patient satisfaction were assessed using Chi-square tests for categorical variables and Kruskal-Wallis tests for continuous variables.

Results: The questionnaire was completed by 907 RA patients (90% women), with 58 (11) years mean (SD) age and 11 (10) years since diagnosis. 82% (n=740) responded to the question “How do you think your healthcare provider’s treatment goals differ from your own goals?”. Of those, 53% (n=392) did not differ (“aligned” with their providers’ goals); 47% (n=348) reported one or more reasons they differed with respect to treatment goals (“non-aligned”). Patient satisfaction was highest in those aligned with their providers’ goals (88%), compared to those non-aligned (54%, p< .0001). Among those non-aligned, major themes were providers’ approach (PA, 48%), differences regarding treatment (DT, 49%) and lack of teamwork (LT, 20%). Dissatisfaction was highest within the PA theme, with 49% dissatisfaction compared to only 36% in the non-PA group (p=0.002).

Conclusion: This survey found previously unreported associations between patient satisfaction with RA treatment and discordance with provider’s treatment goals. Our study is unique in that patients are asked about discordance with provider’s goals and their satisfaction with care. Further research should seek greater insight to patient concerns in RA treatment goals and investigate their significance in RA treatment satisfaction.

Supporting image 1

Themes in patients’ discordance with providers’ goals are arranged by levels of patient satisfaction with rheumatology care.

Supporting image 2

The three major themes of patient goal discordance, lack of teamwork, provider’s approach, and difference regarding treatment, are divided by patient satisfaction with their rheumatology treatment. Those stating their discordance as provider’s approach had the highest level of dissatisfaction.

Supporting image 3

Respondents are categorized by alignment with their provider’s goals and by satisfaction with rheumatology care. Those who considered their goals aligned with their provider’s were more satisfied with their rheumatology care.


Disclosures: K. O'Neill, None; P. Sinicrope, None; C. Crowson, None; K. Marks, None; R. Giblon, None; E. Myasoedova, None; J. Davis, Pfizer.

To cite this abstract in AMA style:

O'Neill K, Sinicrope P, Crowson C, Marks K, Giblon R, Myasoedova E, Davis J. Satisfaction with Rheumatoid Arthritis Care Is Related to Discordance with Providers’ Treatment Goals and Patients’ Reasons for Disagreement [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/satisfaction-with-rheumatoid-arthritis-care-is-related-to-discordance-with-providers-treatment-goals-and-patients-reasons-for-disagreement/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/satisfaction-with-rheumatoid-arthritis-care-is-related-to-discordance-with-providers-treatment-goals-and-patients-reasons-for-disagreement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology